Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wittmer, V. L.
Right arrow Articles by Vasquez, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wittmer, V. L.
Right arrow Articles by Vasquez, E. C.
(Chest. 2006;130:157-163.)
© 2006 American College of Chest Physicians

Effects of Continuous Positive Airway Pressure on Pulmonary Function and Exercise Tolerance in Patients With Congestive Heart Failure*

Veronica L. Wittmer, MSc; Giovana M. S. Simoes, MSc; Luciana C. M. Sogame, PhD and Elisardo C. Vasquez, PhD

* From the Physiological Sciences Graduate Program (Ms. Wittmer and Ms. Simoes), Biomedical Center, Federal University of Espirito Santo; and Emescam College of Health Sciences of Vitoria (Drs. Sogame and Vasquez), Vitoria, Brazil.

Correspondence to: Elisardo C Vasquez, PhD, Physiological Sciences Graduate Program, Biomedical Center, Federal University of Espirito Santo, Av. Marechal Campos 1468, Vitoria, 29042–755 ES, Brazil; e-mail: evasquez{at}terra.com.br

Abstract

Study objectives: Continuous positive airway pressure (CPAP) has been used to improve cardiopulmonary function and reduce pulmonary edema symptoms in patients with congestive heart failure (CHF). The objective of this study was to evaluate the efficacy of CPAP therapy on pulmonary function and exercise tolerance in patients with CHF.

Design: Prospective blind randomized clinical study.

Participants: Twenty-four patients with class II or III CHF and dilated cardiomyopathy were randomly assigned to 30 min of CPAP therapy and respiratory exercises (CPAP group) or respiratory exercise only (control group) once a day for 14 days.

Measurements and results: Evaluation of pulmonary function was performed measuring FEV1 and FVC. Exercise tolerance was assessed measuring the distance walked during the 6-min walking test (6MWT). These parameters were measured before treatment and 4 days, 9 days, and 14 days later. CPAP therapy caused a progressive increase (p < 0.05) in both FVC (maximum of 16% after 9 days) and FEV1 (maximum of 14% after 14 days) compared to basal values, without significant changes in the control group. The 6MWT showed a progressive improvement in the distance walked in the CPAP group, reaching approximately 28% above the basal values in the CPAP group and without significant changes in the control group.

Conclusions: These data show that the use of CPAP therapy for 2 weeks on a daily basis is able to enhance pulmonary function and consequently improve the tolerance to physical activities in patients with CHF. The clinical implication of this finding is that CPAP therapy could potentially be used as an adjunct to the treatment of CHF patients.

Key Words: continuous positive airway pressure ventilation • exercise tolerance • FVC • heart failure • pulmonary function test






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Chest Physicians.